S9, Ep 12- What’s Coming For Rheumatology: Why Conferences Like EULAR Matter for Patients
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
What actually happens at a major international medical conference — and why should patients care?
In this episode of The Health Advocates, Steven Newmark reports from EULAR 2026 in London, one of the world’s largest rheumatology conferences, to explain how meetings like this help shape the future of patient care. The episode explores why conferences matter not just for doctors and researchers, but for patients and advocacy organizations as well.
Steven discusses how practicing clinicians learn about the latest medical advances, how researchers connect directly with physicians treating patients every day, and why organizations like GHLF play an important role in bringing real-world patient experiences into scientific and medical conversations.
The episode also highlights several emerging themes already generating excitement at EULAR this year, including the growing role of artificial intelligence in rheumatology and the potential future of CAR-T and cell therapies for autoimmune diseases like lupus and rheumatoid arthritis.
Most importantly, the conversation explains how scientific innovation ultimately connects back to what matters most: improving the daily lives of patients.
Contact Our Host
Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org
A podcast episode produced by Amelia Violet Prouse, Associate Podcast & Video Producer at GHLF.
We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org
Listen to all episodes of The Health Advocates on our website or on your favorite podcast channel.
See omnystudio.com/listener for privacy information.